Martha J. Carter

2021

In 2021, Martha J. Carter earned a total compensation of $1.7M as Chief Regulatory Officer at Biodel, a 29% increase compared to previous year.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$232,552
Option Awards$826,656
Salary$415,271
Stock Awards$191,840
Other$12,866
Total$1,729,185

Carter received $826.7K in option awards, accounting for 48% of the total pay in 2021.

Carter also received $50K in bonus, $232.6K in non-equity incentive plan, $415.3K in salary, $191.8K in stock awards and $12.9K in other compensation.

Rankings

In 2021, Martha J. Carter's compensation ranked 6,646th out of 12,406 executives tracked by ExecPay. In other words, Carter earned more than 46.4% of executives.

ClassificationRankingPercentile
All
6,646
out of 12,406
46th
Division
Manufacturing
2,871
out of 5,492
48th
Major group
Chemicals And Allied Products
1,263
out of 2,368
47th
Industry group
Drugs
1,127
out of 2,089
46th
Industry
Pharmaceutical Preparations
818
out of 1,536
47th
Source: SEC filing on April 21, 2022.

Carter's colleagues

We found three more compensation records of executives who worked with Martha J. Carter at Biodel in 2021.

2021

Ronald Cooper

Biodel

Chief Executive Officer

2021

Patrick Horn

Biodel

Chief Medical Officer

2021

Simon Harford

Biodel

Chief Financial Officer

News

You may also like